These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Involvement of Grb2 adaptor protein in nucleophosmin-anaplastic lymphoma kinase (NPM-ALK)-mediated signaling and anaplastic large cell lymphoma growth. Riera L; Lasorsa E; Ambrogio C; Surrenti N; Voena C; Chiarle R J Biol Chem; 2010 Aug; 285(34):26441-50. PubMed ID: 20554525 [TBL] [Abstract][Full Text] [Related]
25. NPM-ALK transgenic mice spontaneously develop T-cell lymphomas and plasma cell tumors. Chiarle R; Gong JZ; Guasparri I; Pesci A; Cai J; Liu J; Simmons WJ; Dhall G; Howes J; Piva R; Inghirami G Blood; 2003 Mar; 101(5):1919-27. PubMed ID: 12424201 [TBL] [Abstract][Full Text] [Related]
26. C/EBPβ expression in ALK-positive anaplastic large cell lymphomas is required for cell proliferation and is induced by the STAT3 signaling pathway. Anastasov N; Bonzheim I; Rudelius M; Klier M; Dau T; Angermeier D; Duyster J; Pittaluga S; Fend F; Raffeld M; Quintanilla-Martinez L Haematologica; 2010 May; 95(5):760-7. PubMed ID: 20015877 [TBL] [Abstract][Full Text] [Related]
27. The acetylation of STAT3 at K685 attenuates NPM-ALK-induced tumorigenesis. Korai A; Lin X; Tago K; Funakoshi-Tago M Cell Signal; 2024 Feb; 114():110985. PubMed ID: 38000524 [TBL] [Abstract][Full Text] [Related]
28. IL-21 contributes to JAK3/STAT3 activation and promotes cell growth in ALK-positive anaplastic large cell lymphoma. Dien Bard J; Gelebart P; Anand M; Zak Z; Hegazy SA; Amin HM; Lai R Am J Pathol; 2009 Aug; 175(2):825-34. PubMed ID: 19608866 [TBL] [Abstract][Full Text] [Related]
30. Nucleophosmin-anaplastic lymphoma kinase of anaplastic large-cell lymphoma recruits, activates, and uses pp60c-src to mediate its mitogenicity. Cussac D; Greenland C; Roche S; Bai RY; Duyster J; Morris SW; Delsol G; Allouche M; Payrastre B Blood; 2004 Feb; 103(4):1464-71. PubMed ID: 14563642 [TBL] [Abstract][Full Text] [Related]
31. Anaplastic lymphoma kinase (ALK)-induced malignancies: novel mechanisms of cell transformation and potential therapeutic approaches. Wasik MA; Zhang Q; Marzec M; Kasprzycka M; Wang HY; Liu X Semin Oncol; 2009 Apr; 36(2 Suppl 1):S27-35. PubMed ID: 19393833 [TBL] [Abstract][Full Text] [Related]
32. Oncogenic tyrosine kinase NPM/ALK induces activation of the MEK/ERK signaling pathway independently of c-Raf. Marzec M; Kasprzycka M; Liu X; Raghunath PN; Wlodarski P; Wasik MA Oncogene; 2007 Feb; 26(6):813-21. PubMed ID: 16909118 [TBL] [Abstract][Full Text] [Related]
33. Jak3 activation is significantly associated with ALK expression in anaplastic large cell lymphoma. Lai R; Rassidakis GZ; Lin Q; Atwell C; Medeiros LJ; Amin HM Hum Pathol; 2005 Sep; 36(9):939-44. PubMed ID: 16153455 [TBL] [Abstract][Full Text] [Related]
34. Role of phosphatidylinositol 3-kinase-Akt pathway in nucleophosmin/anaplastic lymphoma kinase-mediated lymphomagenesis. Slupianek A; Nieborowska-Skorska M; Hoser G; Morrione A; Majewski M; Xue L; Morris SW; Wasik MA; Skorski T Cancer Res; 2001 Mar; 61(5):2194-9. PubMed ID: 11280786 [TBL] [Abstract][Full Text] [Related]
35. Model of inhibition of the NPM-ALK kinase activity by herbimycin A. Turturro F; Arnold MD; Frist AY; Pulford K Clin Cancer Res; 2002 Jan; 8(1):240-5. PubMed ID: 11801565 [TBL] [Abstract][Full Text] [Related]
36. Induction of Transcriptional Inhibitor HES1 and the Related Repression of Tumor-Suppressor TXNIP Are Important Components of Cell-Transformation Program Imposed by Oncogenic Kinase NPM-ALK. Zhang Q; Wang HY; Nayak A; Nunez-Cruz S; Slupianek A; Liu X; Basappa J; Fan JS; Chekol S; Nejati R; Bogusz AM; Turner SD; Swaminathan K; Wasik MA Am J Pathol; 2022 Aug; 192(8):1186-1198. PubMed ID: 35640677 [TBL] [Abstract][Full Text] [Related]
37. IL-2R common gamma-chain is epigenetically silenced by nucleophosphin-anaplastic lymphoma kinase (NPM-ALK) and acts as a tumor suppressor by targeting NPM-ALK. Zhang Q; Wang HY; Liu X; Bhutani G; Kantekure K; Wasik M Proc Natl Acad Sci U S A; 2011 Jul; 108(29):11977-82. PubMed ID: 21715655 [TBL] [Abstract][Full Text] [Related]
38. Expression of the oncogenic NPM-ALK chimeric protein in human lymphoid T-cells inhibits drug-induced, but not Fas-induced apoptosis. Greenland C; Touriol C; Chevillard G; Morris SW; Bai R; Duyster J; Delsol G; Allouche M Oncogene; 2001 Nov; 20(50):7386-97. PubMed ID: 11704868 [TBL] [Abstract][Full Text] [Related]